The segment is impelled by the broad use and proven efficacy of various injectable formulations, including dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy), and liraglutide (Victoza, Saxenda) in managing type 2 diabetes and obesity
Insane that 4 out of 10 of those are diet/lifestyle related
Recent Updates Eli Lilly's Strategic Expansion: Eli Lilly's $6.5 billion investment in a new manufacturing facility underscores its commitment to scaling production of GLP-1 therapies
Sources NIDDK Prescription Medications to Treat Overweight and Obesity Wegovy Prescribing Information FDA Semaglutide Injection MedlinePlus Dr
Stay ahead of the curve with valuable resources and strategic recommendations
Christophe Arbet-Engels, MD, Chief Medical Officer